FDA Investigator Laura M Howard
Laura M Howard has conducted inspections on 8 sites in 2 countries as of 04 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
8
Last Inspection Date:
04 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Laura M Howard:
Alia Legaux,
Amy Kim,
Amy Wyan Mai,
Andrew F Cohen,
Azza Talaat,
Barbara Paul,
Burnell M Henry,
Dale A Nyberg,
Dave M Deroche,
Dipesh K Shah,
Donald J Ullstrom,
Dr. Barbara D Paul, PhD,
Dr. Gang Wang, PhD,
Evelyn Taha,
Gene D Arcy,
Gloria E Parra,
Haydee B Romero,
Irina Gaberman,
Jacqueline Mdiaz Albertini,
James A Liubicich,
Janet L Bowen,
Joyce A Bradshaw,
Laura Schankweiler,
Leena Thomas,
Lisa Mathew,
LTJG Matthew R Palo,
Manhar R Patel,
Mercy O Quagraine,
Michael R Dominick,
Mohammad Heidaran, PhD,
Perez,
Peter Abel,
Peter R Caparelli,
Peter Sparell,
Valerie Jgrecek Trinh,
Yong Hu
Laura M Howard's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2001 | EIR | New York Blood Center, Inc. - EIR, 2001-05-21 |
February, 2003 | FDA 483 | New York Blood Center Enterprises - Form 483, 2003-02-28 |
May, 2001 | FDA 483 Response | New York Blood Center, Inc. - Form 483R, 2001-08-15 |
February, 2003 | FDA 483 Response | New York Blood Center Enterprises - Form 483R, 2003-04-21 |
May, 2001 | FDA 483 | New York Blood Center, Inc. - Form 483, 2001-05-21 |
March, 2000 | FDA 483 | New York Blood Center Enterprises - Form 483, 2000-03-20 |
June, 2002 | FDA 483 | Sigma-Aldrich Company Ltd. - Form 483, 2002-06-20 |
March, 2000 | EIR | New York Blood Center Enterprises - EIR, 2000-03-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more